Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-15

Clinical Trial Update: Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis [Phase 4]

View source ↗

Summary

Phase 4 trial update examining sympathetic activity in patients with end-stage renal disease on peritoneal dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: End-stage Renal Disease (ESRD), Kidney Disease | Phase 4 | Status: COMPLETED